Asia (Japan, South Korea, China, India, ASEAN) Alcohol Dependency Treatment Market Is Estimated To Witness High Growth Owing To Rising Awareness Programs
Market Overview:
The Asia (Japan, South Korea, China, India, ASEAN) alcohol dependency treatment market includes products such as therapy, drugs and medications to treat alcohol addiction and dependence patients. The therapy includes various counseling and support therapies such as cognitive behavioral therapy, motivational interviewing therapy, etc. The drugs and medications include disulfiram, naltrexone, acamprosate, topiramate, etc. which are used to treat symptoms of withdrawal and dependency to reduce craving.
Market Dynamics:
Rising awareness programs about risks associated with heavy alcohol consumption and availability of various treatment options are expected to fuel the growth of Asia (Japan, South Korea, China, India, ASEAN) alcohol dependency treatment market over the forecast period. According to a WHO report, Asia Pacific region has highest number of people suffering from mental and substance use disorders including alcohol dependency. The governments in countries like China, South Korea, India are launching dedicated programs to spread awareness about substance abuse and associated health issues. They are also spreading awareness about availability of various affordable treatment options. Furthermore, advancements in therapy techniques and development of new medications are also expected to boost the market growth during forecast period.
The global Asia (Japan, South Korea, China, India, ASEAN) Alcohol Dependency Treatment Market Size is estimated to be valued at Us$ 2.9 Bn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
Strength: The Asia (Japan, South Korea, China, India, ASEAN) Alcohol Dependency Treatment Market has abundant resources and advanced treatment facilities. There is a strong support system of governments, NGOs and medical professionals. Treatments available range from medication, counseling to rehabilitation programs.
Weakness: Social stigma around alcohol dependency and lack of awareness remains significant barrier. Access to affordable treatment is still a challenge in rural areas. Shortage of trained medical staff and counselors in some countries.
Opportunity: Rapid economic growth in the region is driving increasing disposable incomes and changing lifestyles leading to rising alcohol consumption. Government initiatives to boost healthcare spending on alcohol dependency can boost the market.
Threats: Alternative treatment therapies like traditional medicines can divert patients. Strict regulations around alcohol consumption in some Asian nations may hinder overall demand. Pricing pressures from local and generic drug makers impact revenue of international players.
Key Takeaways
The Asia (Japan, South Korea, China, India, ASEAN) Alcohol Dependency Treatment Market size is expected to witness high growth, exhibiting CAGR of 6.6% over the forecast period, due to increasing disposable incomes in the region driving alcohol consumption rates higher.
Regional analysis:
China dominates the regional market accounting for over 30% revenue share in 2023 led by massive population, growing middle class and increasing westernization. India is projected to be the fastest growing market exhibiting 8% CAGR during the forecast period backed by large population suffering from alcohol use disorders and rising healthcare infrastructure.
Key players:
Key players operating in the Asia (Japan, South Korea, China, India, ASEAN) Alcohol Dependency Treatment Market are Kurihama Medical and Addiction Center, National Hospital Organization Kurihama Medical and Addiction Center, Osaka National Hospital, National Hospital Organization Nagasaki Medical Center, National Hospital Organization Kochi Medical Center, National Center for Mental Health (Nashilgil Hospital), Seoul St. Mary's Hospital, Samsung Medical Center, Yonsei University Health System, Asan Medical Center, Beijing HuiLongGuan Hospital, Peking University Sixth Hospital, Beijing Huilongguan Hospital, Shanghai Mental Health Center, Tongji Medical College, Huazhong University of Science and Technology, National Institute of Mental Health and Neurosciences (NIMHANS), All India Institute of Medical Sciences (AIIMS), Tata Memorial Hospital, VIMHANS (Vidyasagar Institute of Mental Health and Neurosciences), Schizophrenia Research Foundation (SCARF), Promises Healthcare (Singapore), The Cabin Chiang Mai (Thailand), The Dawn Medical Rehab and Wellness (Thailand), The Solace Sabah (Malaysia), The Kusnacht Practice (Singapore).
Read More: https://blogger-veritas.blogspot.com/2023/11/psychological-therapies-and-counselling.html
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian